Cytosorbents
CTSO
#9820
Rank
NZ$81.47 M
Marketcap
NZ$1.30
Share price
3.63%
Change (1 day)
-13.92%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -NZ$20.07 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$36.1 Million. In 2024 the company made an earning of -NZ$38.57 Million, an increase over its 2023 earnings that were of -NZ$50.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$20.07 Million-47.96%
2024 -NZ$38.57 Million-23.97%
2023 -NZ$50.73 Million-13.52%
2022 -NZ$58.66 Million34.04%
2021 -NZ$43.76 Million182.17%
2020 -NZ$15.51 Million-55.97%
2019 -NZ$35.22 Million14.17%
2018 -NZ$30.85 Million95.14%
2017 -NZ$15.81 Million-22.32%
2016 -NZ$20.35 Million39.1%
2015 -NZ$14.63 Million-12.89%
2014 -NZ$16.8 Million89%
2013 -NZ$8.89 Million26.65%
2012 -NZ$7.02 Million-26.02%
2011 -NZ$9.49 Million-288.45%
2010 NZ$5.03 M-4.17%
2009 NZ$5.25 M-287.19%
2008 -NZ$2.81 Million-47.12%
2007 -NZ$5.31 Million41.78%
2006 -NZ$3.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
NZ$96.02 M-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.37 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$5.65 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA